ADME Study of [14C]- Larotinib in Healthy Male Subjects

Clinical trial NCT05059743 · COMPLETED

Trial details

NCT number: NCT05059743
Sponsor: Sunshine Lake Pharma Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Male Volunteers

Start date: 2021-11-20
Primary completion: 2022-01-10
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.